Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 5/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | ELANE | P08246 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.36 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.34 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | GFER | P55789 | 1/20 | 0.34 |
| ▸ | DAO | P14920 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4799721 | 1.00 | MEN1 (0.55) | MEN1KMT2ARAB9AGAALMNA | |
| SCHEMBL9189393 | 1.00 | MEN1 (0.55) | MEN1KMT2ARAB9AGAALMNA | |
| SCHEMBL5479525 | 0.91 | MEN1 (0.61) | MEN1KMT2ARAB9AGAALMNA | |
| SCHEMBL17988346 | 0.91 | MEN1 (0.56) | MEN1KMT2ARAB9AGAALMNA | |
| SCHEMBL5479522 | 0.91 | MEN1 (0.61) | MEN1KMT2ARAB9AGAALMNA | |
| SCHEMBL182715 | 0.90 | MEN1 (0.54) | MEN1KMT2ARAB9AGAALMNA | |
| SCHEMBL10050933 | 0.90 | MEN1 (0.54) | MEN1KMT2ARAB9AGAALMNA | |
| SCHEMBL182714 | 0.90 | MEN1 (0.54) | MEN1KMT2ARAB9AGAALMNA | |
| SCHEMBL6878397 | 0.86 | MEN1 (0.47) | MEN1KMT2ARAB9AGAALMNA | |
| SCHEMBL20385256 | 0.86 | MEN1 (0.47) | MEN1KMT2ARAB9AGAALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9411226-B2 | Chemically amplified resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2016-08-09 | — | — | US | disclosed |
| US-9411226-B2 | Chemically amplified resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2016-08-09 | — | — | US | disclosed |
| EP-1769103-B1 | ELECTROCHEMICAL PROCESS FOR PREPARING CYCLOPROPYLBENZYLAMINES | BASF SE (DE) | 2010-05-05 | — | — | EP | disclosed |
| EP-1769103-B1 | ELECTROCHEMICAL PROCESS FOR PREPARING CYCLOPROPYLBENZYLAMINES | BASF SE (DE) | 2010-05-05 | — | — | EP | disclosed |
| US-7411094-B2 | Method for the production of primary amines comprising a primary amino group which bound to an aliphatic or cycloaliphatic C-atom, and a cyclopropyl unit | BASF AKTIENGESELLSCHAFT (DE) | 2008-08-12 | — | — | US | disclosed |
| US-20080064901-A1 | Method for the Production of Primary Amines Comprising a Primary Amino Group Which is Bound to an Aliphatic or Cycloaliphatic C-Atom, and a Cyclopropyl Unit | BASF (DE) | 2008-03-13 | — | — | US | disclosed |
| EP-1769103-A1 | METHOD FOR THE PRODUCTION OF PRIMARY AMINES COMPRISING A PRIMARY AMINO GROUP WHICH IS BOUND TO AN ALIPHATIC OR CYCLOALIPHATIC C-ATOM, AND A CYCLOPROPYL UNIT | BASF AKTIENGESELLSCHAFT (DE) | 2007-04-04 | — | — | EP | disclosed |
| WO-2006005531-A1 | METHOD FOR THE PRODUCTION OF PRIMARY AMINES COMPRISING A PRIMARY AMINO GROUP WHICH IS BOUND TO AN ALIPHATIC OR CYCLOALIPHATIC C-ATOM, AND A CYCLOPROPYL UNIT | BASF AKTIENGESELLSCHAFT (DE) | 2006-01-19 | — | — | WO | disclosed |
| US-5464847-A | Moduators of corticotropin releasing factor | ELF SANOFI (FR) | 1995-11-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080064901-A1 | Method for the Production of Primary Amines Comprising a Primary Amino Group Which is Bound to an Aliphatic or Cycloaliphatic C-Atom, and a Cyclopropyl Unit | CYCS, DAO, MAOB | MEN1 2005/4885KMT2A 881/4885RAB9A 2950/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.